{"id":"W2067495120","doi":"10.1007/s00280-011-1606-z","title":"A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer","year":2011,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"FOLFOX; Oxaliplatin; Bevacizumab; Capecitabine; Medicine; Pharmacokinetics; Dosing; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Pharmacology; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002637027,0.001963218,0.003758426,0.0004154304,0.0006963162,0.001325841,0.001021857,0.001816897,0.003646304],"category_scores_gemma":[0.003056612,0.001138142,0.001707731,0.0006214867,0.002283104,0.002306094,0.0005731447,0.004270239,0.0008413109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001415505,"about_ca_system_score_gemma":0.002103004,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001160899,"about_ca_topic_score_gemma":0.001884207,"domain_scores_codex":[0.9985132,0.0008199163,0.0000674817,0.0003130763,0.00009566792,0.0001905872],"domain_scores_gemma":[0.9972445,0.0006826812,0.0006708734,0.0003441535,0.0001403881,0.0009174459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9780787,0.01066291,0.001354364,0.00006553583,0.0003062598,0.00002077308,0.00004342155,0.0003189671,0.003206612,0.00005091791,0.0002393583,0.00565222],"study_design_scores_gemma":[0.8211612,0.1731768,0.003731384,0.000006813363,0.0002836256,0.00003623117,0.00002193649,0.0006739995,0.000490386,0.00008312368,0.0003143587,0.00002014943],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969978,0.0005246936,0.0004413947,0.0002362281,0.0001441002,0.0008940102,0.0002995856,0.00005025339,0.0004119516],"genre_scores_gemma":[0.9942071,0.0004164438,0.001387935,0.0005516189,0.0003611735,0.00135266,0.0007689504,0.00003107987,0.0009230807],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003758426,"threshold_uncertainty_score":0.01394612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06911846102860347,"score_gpt":0.3775572727830627,"score_spread":0.3084388117544593,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}